Cargando…
Dialysate calcium, alfacalcidol, and clinical outcomes: A post-hoc analysis of the J-DAVID trial
The selection of dialysate calcium concentration (D-Ca) is still controversial among chronic hemodialysis (HD) regimens. We examined the trajectories of CKD MBD parameters among the J-DAVID trial participants to see the effect of D-Ca and alfacalcidol. The trial was an open-label randomized clinical...
Autores principales: | Iseki, Kunitoshi, Kabata, Daijiro, Shoji, Tetsuo, Inaba, Masaaki, Emoto, Masanori, Mori, Katsuhito, Morioka, Tomoaki, Nakatani, Shinya, Shintani, Ayumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451061/ https://www.ncbi.nlm.nih.gov/pubmed/36070301 http://dx.doi.org/10.1371/journal.pone.0273195 |
Ejemplares similares
-
Effects of alfacalcidol on cardiovascular outcomes according to alkaline phosphatase levels in the J-DAVID trial
por: Oka, Tatsufumi, et al.
Publicado: (2022) -
Associations of time-dependent changes in phosphorus levels with cardiovascular diseases in patients undergoing hemodialysis: results from the Japan Dialysis Active Vitamin D (J-DAVID) randomized clinical trial
por: Koshi-Ito, Eri, et al.
Publicado: (2022) -
Oxidative Stress and Inflammation as Predictors of Mortality and Cardiovascular Events in Hemodialysis Patients: The DREAM Cohort
por: Sasaki, Keyaki, et al.
Publicado: (2021) -
Plasma homocysteine and cerebral small vessel disease as possible mediators between kidney and cognitive functions in patients with diabetes mellitus
por: Sonoda, Mika, et al.
Publicado: (2017) -
Association between Levocarnitine Treatment and the Change in Knee Extensor Strength in Patients Undergoing Hemodialysis: A Post-Hoc Analysis of the Osaka Dialysis Complication Study (ODCS)
por: Matsufuji, Shota, et al.
Publicado: (2022)